SEARCH

SEARCH BY CITATION

Literature cited

  • Barrick, J. E., D. S. Yu, S. H. Yoon, H. Jeong, T. K. Oh, D. Schneider, R. E. Lenski et al. 2009. Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 461:12431247.
  • Beckman, R. A. 2009. Mutator mutations enhance tumorigenic efficiency across fitness landscapes. PLoS ONE 4:e5860.
  • Beckman, R. A. 2010. Efficiency of carcinogenesis: is the mutator phenotype inevitable? Seminars in Cancer Biology 20:340352.
  • Beckman, R. A., and L. A. Loeb 2005. Negative clonal selection in tumor evolution. Genetics 171:21232131.
  • Beckman, R. A., and L. A. Loeb 2006. Efficiency of carcinogenesis with and without a mutator mutation. Proceedings of National Academy of Science of the United States of America 103:1414014145.
  • Beerenwinkel, N., T. Antal, D. Dingli, A. Traulsen, K. W. Kinzler, V. E. Velculescu, B. Vogelstein et al. 2007. Genetic progression and the waiting time to cancer. PLoS Computational Biology 3:e225.
  • Birkbak, N. J., A. C. Eklund, Q. Li, S. E. McClelland, D. Endesfelder, P. Tan, I. B. Tan et al. 2011. Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Research 71:34473452.
  • Bodmer, W., J. H. Bielas, and R. A. Beckman 2008. Genetic instability is not a requirement for tumor development. Cancer Research 68:35583560; discussion 3560-1.
  • Bozic, I., T. Antal, H. Ohtsuki, H. Carter, D. Kim, S. Chen, R. Karchin et al. 2010. Accumulation of driver and passenger mutations during tumor progression. Proceedings of the National Academy of Sciences of the United States of America 107(43):1854550.
  • Cahill, D. P., K. W. Kinzler, B. Vogelstein, and C. Lengauer 1999. Genetic instability and darwinian selection in tumours. Trends in Cell Biology 9:M57M60.
  • Durrett, R., J. Foo, K. Leder, J. Mayberry, and F. Michor 2011. Intratumor heterogeneity in evolutionary models of tumor progression. Genetics 188:461477.
  • Fearon, E. R. 2011. Molecular genetics of colorectal cancer. Annual Review of Pathology: Mechanisms of Disease 6:479507.
  • Fodde, R., J. Kuipers, C. Rosenberg, R. Smits, M. Kielman, C. Gaspar, J. H. van Es et al. 2001. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nature Cell Biology 3:433438.
  • Gerlinger, M., A. J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez et al. 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine 366:883892.
  • Hornsby, C., K. M. Page, and I. P. M. Tomlinson 2007. What can we learn from the population incidence of cancer? Armitage and Doll revisited. The lancet oncology 8:10301038.
  • Komarova, N. L., and D. Wodarz 2004. The optimal rate of chromosome loss for the inactivation of tumor suppressor genes in cancer. Proceedings of National Academy of Science of the United States of America 101:70177021.
  • Komarova, N. L., A. V. Sadovsky, and F. Y. Wan 2008. Selective pressures for and against genetic instability in cancer: a time-dependent problem. Journal of the Royal Society, Interface 5:105121.
  • Lamlum, H., A. Papadopoulou, M. Ilyas, A. Rowan, C. Gillet, A. Hanby, I. Talbot et al. 2000. Adenomatous polyposis coli (APC) mutations are sufficient for the growth of early colorectal adenomas. Proceedings of the National Academy of Sciences of the United States of America 97:22252228.
  • Lee, A. J., D. Endesfelder, A. J. Rowan, A. Walther, N. J. Birkbak, P. A. Futreal, J. Downward et al. 2011. Chromosomal instability confers intrinsic multidrug resistance. Cancer Research 71:18581870.
  • Loeb, L. A. 2001. A mutator phenotype in cancer. Cancer Research 61:32303239.
  • Loeb, L. A. 2011. Human cancers express mutator phenotypes: origin, consequences and targeting. Nature Reviews Cancer 11:450457.
  • Luebeck, E. G., and S. H. Moolgavkar 2002. Multistage carcinogenesis and the incidence of colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 99:1509515100.
  • Maley, C. C., and S. Forrest 2000. Exploring the relationship between neutral and selective mutations in cancer. Artificial Life 6:325345.
  • Maley, C. C., P. C. Galipeau, X. Li, C. A. Sanchez, T. G. Paulson, P. L. Blount, and B. J. Reid 2004. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Research 64:76297633.
  • Maley, C. C., P. C. Galipeau, J. C. Finley, V. J. Wongsurawat, X. Li, C. A. Sanchez, T. G. Paulson et al. 2006. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genetics 38:468473.
  • Markowitz, S. D., and M. M. Bertagnolli 2009. Molecular origins of cancer: molecular basis of colorectal cancer. New England Journal of Medicine 361:24492460.
  • Martens, E. A., R. Kostadinov, C. C. Maley, and O. Hallatschek 2011. Spatial structure increases the waiting time for cancer. New Journal of Physics 13:11504.
  • Rabinovitch, P. S., S. Dziadon, T. A. Brentnall, M. J. Emond, D. A. Crispin, R. C. Haggitt, and M. P. Bronner 1999. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Research 59:51485153.
  • Rajagopalan, H., M. A. Nowak, B. Vogelstein, and C. Lengauer 2003. The significance of unstable chromosomes in colorectal cancer. Nature Reviews Cancer 3:695701.
  • Roylance, R., D. Endesfelder, P. Gorman, R. A. Burrell, J. Sander, I. Tomlinson, A. M. Hanby et al. 2011. Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer. Cancer Epidemiology Biomarkers Prevention 20:21832194.
  • Salk, J. J., E. J. Fox, and L. A. Loeb 2010. Mutational heterogeneity in human cancers: origin and consequences. Annual Review of Pathology 5:5175.
  • Schollnberger, H., N. Beerenwinkel, R. Hoogenveen, and P. Vineis 2010. Cell selection as driving force in lung and colon carcinogenesis. Cancer Research 70:67976803.
  • Siegmund, K. D., P. Marjoram, S. Tavare, and D. Shibata 2011. High DNA methylation pattern intratumoral diversity implies weak selection in many human colorectal cancers. PLoS ONE 6:e21657.
  • Sjöblom, T., S. Jones, L. D. Wood, D. W. Parsons, J. Lin, T. D. Barber, D. Mandelker et al. 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314:268274.
  • Sniegowski, P. D., P. J. Gerrish, and R. E. Lenski 1997. Evolution of high mutation rates in experimental populations of E. coli. Nature 387:703705.
  • Song, H., M. Hollstein, and Y. Xu 2007. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nature Cell Biology 9:573580.
  • Taddei, F., M. Radman, J. Maynard-Smith, B. Toupance, P. H. Gouyon, and B. Godelle 1997. Role of mutator alleles in adaptive evolution. Nature 387:700702.
  • Tomlinson, I., and W. Bodmer 1999. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nature Medicine 5:1112.
  • Tomlinson, I. P., M. R. Novelli, and W. F. Bodmer 1996. The mutation rate and cancer. Proceedings of the National Academy of Sciences of the United States of America 93:1480014803.
  • Walther, A., R. Houlston, and I. Tomlinson 2008. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 57:941950.